NOK78 2.4 3.2%
Last Trade - 5:00pm
| Market Cap | £340.0m |
| Enterprise Value | £329.3m |
| Revenue | £7.88m |
| Position in Universe | 569th / 1850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 | 71.9 | 66.7 | 66.8 | 45.2 | 93.4 | +11.9% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Arcticzymes Technologies ASA is a Norway-based biopharmaceutical company that develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The Company focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | March 12, 1995 |
| Public Since | November 4, 2005 |
| No. of Shareholders: | n/a |
| No. of Employees: | 38 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm (Dual Listing) |
| Shares in Issue | 48,334,673 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Sykehusveien 23, TROMSO, 9019, Norway |
| Web | https://arcticzymes.com/ |
| Phone | +47 77 648900 |
| Contact | Borge Sorvoll (Chief Financial Officer) |
| Auditors | PricewaterhouseCoopers AS |
As of 5:00pm, shares in Arcticzymes Technologies ASA are trading at NOK78, giving the company a market capitalisation of £340.0m. This share price information is delayed by 15 minutes.
Shares in Arcticzymes Technologies ASA are currently trading at NOK78 and the price has moved by 0.941k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Arcticzymes Technologies ASA price has moved by 0.888k% over the past year.
There are no analysts currently covering Arcticzymes Technologies ASA.
Arcticzymes Technologies ASA is scheduled to issue upcoming financial results on the following dates:
Arcticzymes Technologies ASA does not currently pay a dividend.
Arcticzymes Technologies ASA does not currently pay a dividend.
Arcticzymes Technologies ASA does not currently pay a dividend.
To buy shares in Arcticzymes Technologies ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Arcticzymes Technologies ASA are currently trading at NOK78, giving the company a market capitalisation of £340.0m.
Here are the trading details for Arcticzymes Technologies ASA:
Based on an overall assessment of its quality, value and momentum, Arcticzymes Technologies ASA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Arcticzymes Technologies ASA are currently priced at NOK78. At that level they are trading at 77.51% premium to the analyst consensus target price of 0.00.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arcticzymes Technologies ASA. Over the past six months, the relative strength of its shares against the market has been -0.32%. At the current price of NOK78, shares in Arcticzymes Technologies ASA are trading at 0.126k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Arcticzymes Technologies ASA PE ratio based on its reported earnings over the past 12 months is 63.56. The shares are currently trading at NOK78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Arcticzymes Technologies ASA's management team is headed by:
Here are the top five shareholders of Arcticzymes Technologies ASA based on the size of their shareholding:
